Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Perspective Therapeutics, Inc. Director's Dealing 2007

Sep 13, 2007

33510_dirs_2007-09-13_667e1651-5236-44d9-8fc9-0b085501bcb7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2006-08-15

Reporting Person: Swanberg David (Director, EVP Operations & Secretary)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2006-08-15 stock options (right to buy) $3.11 A 20000 Acquired 2016-08-15 common stock (20000) Indirect

Footnotes

F1: 6,666 stock options vest 8/15/2006, 6,667 stock options vest 8/15/2007, 6,667 stock options vest 8/15/2008.

F2: 20,000 stock options are held indirectly through Mr. Swanberg's spouse. The remaining 300,000 stock options are held directly.